Company Overview and News

 
Dena Bank - Updates

2018-04-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
CBI probing another loan of Rs 5,280 crore taken by Mehul Choksi from ICICI-led banks

2018-04-12 freepressjournal.in
Mumbai: The CBI is probing yet another loan of Rs 5,280 crore extended by a consortium of 31 banks led by the ICICI Bank to companies of absconding billionaire jeweller Mehul Choksi, officials said on Wednesday.
Upvote Downvote

 
Dena Bank - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Reliance subsidiary moves HC seeking attachment of DMRC accounts

2018-04-06 moneycontrol
Reliance Infrastructure's (Rinfra) subsidiary DAMEPL today moved the Delhi High Court seeking attachment of DMRC's bank accounts for not depositing 75 per cent of the over Rs 5,164 crore arbitral award, including interest, within the time given by the court.
Upvote Downvote

 
Dena Bank - Shareholders meeting

2018-03-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Closing Bell: Sensex falls 206 pts, Nifty closes below 10,150 on expiry day; Wipro up 4%

2018-03-28 moneycontrol
3:30 pm Market Closing: Benchmark indices reversed some of gains seen in previous two consecutive sessions, with the Sensex losing 205.71 points to 32,968.68.
Upvote Downvote

 
Market Live: Nifty extends losses ahead of FO expiry, Sensex loses 200 pts

2018-03-28 moneycontrol
3:06 pm Persistent's FY19 Outlook: Persistent Systems clarifed that in terms of the outlook for FY 2018-19, it expects a steady growth in both revenue streams - service revenues and IP revenues.
Upvote Downvote

 
Market Live: Sensex, Nifty Bank fall over 150 pts; Alkem Labs, Persistent dip 10%

2018-03-28 moneycontrol
2:01 pm NLC Deal Called-Off: Damodar Valley Corporation has called off a deal with NLC India for acquisition of DVC's power station through JV.
Upvote Downvote

 
Dena Bank - Appointment

2018-03-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Market Live: Sensex off day#39;s low, Nifty weak ahed of FO expiry; Europe down

2018-03-28 moneycontrol
12:42 pm Buzzing: Shares of Kakatiya Cements added 9 percent intraday as Central Pollution Control Board (CPCB) revokes closure order on company’s cement plant.
Upvote Downvote

 
News Live: Economist fears 30% correction in US mkts

2018-03-28 moneycontrol
Stock markets could see a hefty fall in coming months due to a slew of trends that point to a downturn in the global economy, one economist told CNBC. Steen Jakobsen, the often-bearish Chief Economist at Danish investment house Saxo Bank, cited several factors including growing credit loans, a widening fiscal deficit in the US, doubts over infrastructure spending plans and a potential trade war. In a scenario of a potential sudden economic recession, he sees a possible market correction of between 25% and 30%.
Upvote Downvote

 
Market Live: Sensex, Nifty under pressure; PSU banks, autos, IT rebound

2018-03-28 moneycontrol
12:00 am Order Win: The construction arm of Larsen & Toubro has won orders worth Rs 1,521 crore.
Upvote Downvote

 
News Live: Opposition begins signature drive for Deepak Misra#39;s impeachment

2018-03-28 moneycontrol
The Supreme Court dismissed a plea seeking a re-investigation into the assassination of Mahatma Gandhi, reports PTI. The court said the plea seeking retrial was based on academic research but that could not form the basis to reopen the matter which happened years ago.
Upvote Downvote

 
Market Live: Sensex drops 200 pts, midcaps fall too; Tata Steel, Bharti Airtel dip

2018-03-28 moneycontrol
10:45 am Market Update: The market extended losses on the back of weak global cues, with the Sensex falling 200 points.
Upvote Downvote

 
News Live: Goldman Sachs computer model warns bear market is near

2018-03-28 moneycontrol
Janalakshmi set to launch small fin bank, gets final certificate from RBI, gets final certificate from RBI
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...